Learning from cystic fibrosis: How can we start to personalise treatment of Children's Interstitial Lung Disease (chILD)?

Abstract excerpt

Cystic fibrosis (CF) is a monogenic disorder cause by mutations in the CF Transmembrane Regulator (CFTR) gene. The prognosis of cystic fibrosis has been transformed by the discovery of highly effective modulator therapies (HEMT). Treatment has changed from reactive therapy dealing with complications of the disease to pro-active correction of the underlying molecular functional abnormality. This has come about by...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Child
• Share to Cystic Fibrosis
• Share to Cystic Fibrosis Transmembrane Conductance Regulator